Roelf Valkema
Neuroendocrine tumors. Peptide receptor radionuclide therapy
Forrer F, Valkema R, Kwekkeboom D, de Jong M, Krenning E. Neuroendocrine tumors. Peptide receptor radionuclide therapy. Best Pract Res Clin Endocrinol Metab 2007; 21:111-29.
Mar 1, 2007Neuroendocrine tumors. Peptide receptor radionuclide therapy
Mar 1, 2007Best Pract Res Clin Endocrinol Metab 2007; 21:111-29
Forrer Flavio, Valkema Roelf, Kwekkeboom Dik J, de Jong Marion, Krenning Eric P
Anaphylactoid reaction from amifostine
Rolleman E, Forrer F, Deckers J, de Groot H, Valkema R, de Jong M, Krenning E. Anaphylactoid reaction from amifostine. Radiother Oncol 2006; 82:110-1; author reply 111.
Dec 20, 2006Anaphylactoid reaction from amifostine
Dec 20, 2006Radiother Oncol 2006; 82:110-1; author reply 111
Rolleman Edgar J, Forrer Flavio, Deckers Jaap, de Groot Hans, Valkema Roelf, de Jong Marion, Krenning Eric P
Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate
Rolleman E, Forrer F, Bernard B, Bijster M, Vermeij M, Valkema R, Krenning E, de Jong M. Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate. Eur J Nucl Med Mol Imaging 2006; 34:763-771.
Dec 5, 2006Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate
Dec 5, 2006Eur J Nucl Med Mol Imaging 2006; 34:763-771
Rolleman Edgar J, Forrer Flavio, Bernard Bert, Bijster Magda, Vermeij Marcel, Valkema Roelf, Krenning Eric P, de Jong Marion